SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008; 320: 12201224.
  • 2
    Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U. Natural tregs and persistent viral infections. J Virol 2008; 82: 2130.
  • 3
    Kinter A, McNally J, Riggin L, Jackson R, Roby G, Fauci AS. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIVinfected individuals. Proc Natl Acad Sci USA 2007; 104: 33903395.
  • 4
    Kinter AL, Horak R, Sion M, Riggin L, McNally J, Lin Y, Jackson R, O'Shea A, Roby G, Kovacs C, Connors M, Migueles SA, Fauci AS. CD25_ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8_ T cells in vitro. AIDS Res Hum Retroviruses 2007; 23: 438450.
  • 5
    Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol 2011; 85: 1142211434.
  • 6
    Prendergast A, O'Callaghan M, Menson E, Hamadache D, Walters S, Klein N, Goulder P. Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res Hum Retroviruses. 2012; 28: 465468.
  • 7
    Chase AJ, Yang HC, Zhang H, Blankson JN, Siliciano RF. Preservation of FoxP3R regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4R T-cell activation. J Virol 2008; 82: 83078315.
  • 8
    Moreno-Fernandez ME, Rueda CM, Rusie LK, Chougnet CA. Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 2011; 117: 53725380.
  • 9
    Sattui S, de la Flor C, Sanchez C, Lewis D, Lopez G, Rizo-Patrón E, White AC Jr, Montes M. Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 2012; 82B: 5458.
  • 10
    Venet F, Malcus C, Ferry T, Poitevin F, Monneret G. Percentage of regulatory T cells CD4+CD25+CD127− in HIV-infected patients is not reduced after cryopreservation. J Immunol Methods 2010; 357: 5558.
  • 11
    Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490500.
  • 12
    Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203: 17011711.
  • 13
    Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 16931700.
  • 14
    Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009; 35: 678686.
  • 15
    Del Pozo-Balado Mdel M, Leal M, Méndez-Lagares G, Pacheco YM. CD4+CD25+/hiCD127lo Phenotype Does Not Accurately Identify Regulatory T Cells in All Populations of HIV Infected Persons. J Infect Dis 2010; 201: 331335.
  • 16
    Montes M, Sanchez C, Lewis DE, Graviss EA, Seas C, Gotuzzo E, White AC Jr. Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. J Infect Dis 2011; 203: 496499.
  • 17
    Schulze Zur Wiesch J, Thomssen A, Hartjen P, Tóth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, Degen O, Mauss S, Rockstroh J, Staszewski S, Khaykin P, Strasak A, Lohse AW, Fätkenheuer G, Hauber J, van Lunzen J. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 2011; 85: 12871297.
  • 18
    Méndez-Lagares G, Del Mar Del Pozo-Balado M, Genebat González M, García-Pergañeda Sánchez A, Leal Noval M, Pacheco López YM. Severe immune dysregulation affects CD4+CD25hiFoxP3+ regulatory T-cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive HAART. J Infect Dis 2012;205:15011509.
  • 19
    Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM, McElrath MJ, Horton H. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med 2011; 17: 989995.
  • 20
    Simonetta F, Lecuroux C, Girault I, Goujard C, Sinet M, Lambotte O, Venet A, Bourgeois C. Early and long lasting alteration of Effector CD45RA-Foxp3high Regulatory T cells homeostasis during HIV infection. J Infect Dis 2012;205:15101519.
  • 21
    Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, Norris PJ, Busch MP, Martin JN, Brooks C, McCune JM, Deeks SG. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 2011; 6.
  • 22
    Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, Kalayjian RC, Landay AL. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol 2009; 130: 298303.